General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Amgen Inc.(MODEST), Baxter International Inc(MODEST), Sanofi-Aventis(MODEST), Amgen Inc.(MODEST), Roche(MODEST), Abiomed(MODEST), Johnson & Johnson(MODEST), Cytokinetics(MODEST), Merck & Co., Inc.(MODEST), Regeneron(MODEST), Daiichi Sankyo(MODEST), Bayer Healthcare Pharmaceuticals(MODEST) OTHER FINANCIAL BENEFIT: Abbott Laboratories(SIGNIFICANT), Vifor Pharma(MODEST), AstraZeneca Pharmaceuticals(MODEST), Boehringer Ingelheim Pharmaceuticals, Inc(MODEST), Respicardia/Zoll(MODEST)

View Full Disclosure